Latest filing published 13 Nov 2008 for Achieve Life Sciences, INC., €1,557.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +914.1%Entry US$7,810.00 · Close at T+365 US$79,200.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephen Charles Anderson: trading record in brief
Stephen Charles Anderson is a declared insider of Achieve Life Sciences, Inc., with filings sourced from SEC (Form 4). In total, 10 filings cover trades dated from 26 August 2008 to 13 November 2008.
On the market, this insider has only ever bought: 10 purchases, €103k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Half of the purchases are above €9,032 and half below.
The latest filing, published on 17 November 2008, reports an open-market purchase of €28k in Achieve Life Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen Charles Anderson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 776 shares@ US$2.50Common StockSEC:0001209191-08-060566:0Canonical exit: 10 Feb 2009 (T+90)
- 2,224 shares@ US$2.40Common StockSEC:0001209191-08-060566:1Canonical exit: 11 Feb 2009 (T+90)
- 6,000 shares@ US$6.85Common StockSEC:0001209191-08-049392:0Canonical exit: 24 Nov 2008 (T+90)
- 2,000 shares@ US$6.65Common StockSEC:0001209191-08-049392:1Canonical exit: 24 Nov 2008 (T+90)
4 of 4 declarations